Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary K Collins

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Annals of Health Law|June 8, 2007
Conscience clauses and oral contraceptives: conscientious objection or calculated obstruction?Mary K Collins
Journal of Virology|August 1, 2008
Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restrictionMarie Dewannieux, Mary K Collins
Trends in Biotechnology|November 16, 2004
Gene therapy meets vaccine developmentMary K Collins, Vincenzo Cerundolo
The Journal of Biological Chemistry|May 13, 2005
Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2Emma A Willoughby, Mary K Collins
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Lentivector targeting to dendritic cellsAlexander Ageichik, Mary K Collins, Marie Dewannieux
Human Gene Therapy|January 21, 2011
Lentiviral vectors targeted to MHC II are effective in immunizationAlexander Ageichik, Christian J Buchholz, Mary K Collins
The Journal of Clinical Investigation|June 24, 2009
Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in miceMary K Collins, Chin-Siean Tay, Adrian Erlebacher
The Journal of Gene Medicine|March 12, 2011
A lentiviral vector pseudotype suitable for vaccine developmentLuciene Lopes, Marie Dewannieux, Yasuhiro Takeuchi, et al.
Plos One|January 7, 2014
Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cellsChin-Siean Tay, Elisa Tagliani, Mary K Collins, et al.
Human Gene Therapy|March 6, 2009
Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cellsFrancesca Gennari, Luciene Lopes, Els Verhoeyen, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Annals of Health Law|June 8, 2007
Conscience clauses and oral contraceptives: conscientious objection or calculated obstruction?Mary K Collins
Journal of Virology|August 1, 2008
Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restrictionMarie Dewannieux, Mary K Collins
Trends in Biotechnology|November 16, 2004
Gene therapy meets vaccine developmentMary K Collins, Vincenzo Cerundolo
The Journal of Biological Chemistry|May 13, 2005
Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2Emma A Willoughby, Mary K Collins
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Lentivector targeting to dendritic cellsAlexander Ageichik, Mary K Collins, Marie Dewannieux
Human Gene Therapy|January 21, 2011
Lentiviral vectors targeted to MHC II are effective in immunizationAlexander Ageichik, Christian J Buchholz, Mary K Collins
The Journal of Clinical Investigation|June 24, 2009
Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in miceMary K Collins, Chin-Siean Tay, Adrian Erlebacher
The Journal of Gene Medicine|March 12, 2011
A lentiviral vector pseudotype suitable for vaccine developmentLuciene Lopes, Marie Dewannieux, Yasuhiro Takeuchi, et al.
Plos One|January 7, 2014
Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cellsChin-Siean Tay, Elisa Tagliani, Mary K Collins, et al.
Human Gene Therapy|March 6, 2009
Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cellsFrancesca Gennari, Luciene Lopes, Els Verhoeyen, et al.
Pageof 5